ERBB2 and cancer: Related to prognosis, in one of the studies three features were found to be associated with a higher risk for relapse and with an increased risk of death: CTCs with CSCs and partial EMT features, triple-negative subtype, and liver metastasis in all cancer subtypes, except for the Her2-positive subtype [18].